Precision BioSciences Overview

  • Founded
  • 2006

Founded
  • Status
  • Public

  • Employees
  • 190

Employees
  • Stock Symbol
  • DTIL

Stock Symbol
  • Share Price
  • $1.56

  • (As of Wednesday Closing)

Precision BioSciences General Information

Description

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food out of which the Therapeutics segment act as a key revenue driver for the firm.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 302 East Pettigrew Street
  • Dibrell Building, Suite A-100
  • Durham, NC 27701
  • United States
+1 (919) 000-0000

Precision BioSciences Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Precision BioSciences Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.56 $1.57 $1.11 - $14.38 $110M 62.2M 2.35M -$0.65

Precision BioSciences Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 53,448 300,750 344,503 499,171
Revenue 102,497 115,529 24,285 22,238
EBITDA (30,247) (20,481) (100,015) (91,645)
Net Income (40,081) (30,602) (109,006) (92,877)
Total Assets 181,351 211,498 150,158 235,233
Total Debt 8,683 9,113 10,519 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Precision BioSciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Precision BioSciences‘s full profile, request access.

Request a free trial

Precision BioSciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Precision BioSciences‘s full profile, request access.

Request a free trial

Precision BioSciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, A
Biotechnology
Durham, NC
190 As of 2022
00000
00000000 00000

000000

e irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excep
0000 000000000
Cambridge, MA
000 As of 0000
00000
00000000000 00000

0000 0

rure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteu
0000 000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Precision BioSciences Competitors (63)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Editas Medicine Formerly VC-backed Cambridge, MA 000 00000 00000000000 00000
0000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
0000000 0000000000 Formerly VC-backed San Diego, CA 000 00000 00000000 00000
00000 000000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Berkeley, CA 00 00000 00000000 00000
You’re viewing 5 of 63 competitors. Get the full list »

Precision BioSciences Patents

Precision BioSciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3137975-A1 Optimization of engineered meganucleases for recognition sequences Pending 07-May-2019 0000000000
CA-3136265-A1 Methods of preparing populations of genetically-modified immune cells Pending 05-Apr-2019 0000000000
US-20210254002-A1 Genetically-modified immune cells comprising a microrna-adapted shrna (shrnamir) Granted 03-Apr-2019 0000000000
US-20200370014-A1 Genetically-modified immune cells comprising a microrna-adapted shrna (shrnamir) Granted 03-Apr-2019 0000000000
CA-3135799-A1 Genetically-modified immune cells comprising a microrna-adapted shrna (shrnamir) Pending 03-Apr-2019 C12N5/0636
To view Precision BioSciences’s complete patent history, request access »

Precision BioSciences Executive Team (19)

Name Title Board Seat Contact Info
Michael Amoroso President, Chief Executive Officer & Board Member
Abid Ansari Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Jeff Smith Ph.D Co-Founder & Chief Technology Officer
Juli Blanche Chief People Officer
Derek Jantz Chief Scientific Officer & Founder
You’re viewing 5 of 19 executive team members. Get the full list »

Precision BioSciences Board Members (10)

Name Representing Role Since
Benjamin Belldegrun Aliment Capital Board Observer 000 0000
Geno Germano Self Board Member 000 0000
Kevin Buehler Precision BioSciences Chairman, Chairman of Nominating and Corporate Governance Committee and Member of Audit Committee 000 0000
Michael Amoroso Precision BioSciences President, Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 10 board members. Get the full list »

Precision BioSciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Precision BioSciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Precision BioSciences‘s full profile, request access.

Request a free trial